The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation
Open accessAbstract
Rationale: Aging represents a major risk factor for coronary artery disease and aortic aneurysm formation. MicroRNAs (miRs) have emerged as key regulators of biological processes, but their role in age-associated vascular pathologies is unknown. Objective: We aim to identify miRs in the vasculature that are regulated by age and play a role in age-induced vascular pathologies. Methods and Results: Expression profiling of aortic tissue of young versus old mice identified several age-associated miRs. Among the significantly regulated miRs, the increased expression of miR-29 family members was associated with a profound downregulation of numerous extracellular matrix (ECM) components in aortas of aged mice, suggesting that this miR family contributes to ECM loss, thereby sensitizing the aorta for aneurysm formation. Indeed, miR-29 expression was significantly induced in 2 experimental models for aortic dilation: angiotensin II-treated aged mice and genetically induced aneurysms in Fibulin-4 R/R mice. More importantly, miR-29b levels were profoundly increased in biopsies of human thoracic aneurysms, obtained from patients with either bicuspid ( n =79) or tricuspid aortic valves ( n =30). Finally, LNA-modified antisense oligonucleotide-mediated silencing of miR-29 induced ECM expression and inhibited angiotensin II-induced dilation of the aorta in mice. Conclusion: In conclusion, miR-29-mediated downregulation of ECM proteins may sensitize the aorta to the formation of aneurysms in advanced age. Inhibition of miR-29 in vivo abrogates aortic dilation in mice, suggesting that miR-29 may represent a novel molecular target to augment matrix synthesis and maintain vascular wall structural integrity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903474106 · Cited by 3,524
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834
Singh, K. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.3.236 · Cited by 634
miR-29 miRNAs activate p53 by targeting p85α and CDC42
Park, S.-Y., Lee, J. H., Ha, M., Nam, J.-W., & Kim, V. N. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1533 · Cited by 606
Age-associated Cardiovascular Changes in Health: Impact on Cardiovascular Disease in Older Persons
Lakatta, E. G. (2002) · Heart Failure Reviews · doi:10.1023/a:1013797722156 · Cited by 445
Pathogenesis of Thoracic and Abdominal Aortic Aneurysms
GUO, D., PAPKE, C. L., HE, R., & MILEWICZ, D. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1383.013 · Cited by 280
Detecting microRNA binding and siRNA off-target effects from expression data
van Dongen, S., Abreu-Goodger, C., & Enright, A. J. (2008) · Nature Methods · doi:10.1038/nmeth.1267 · Cited by 273
Aging and chronic DNA damage response activate a regulatory pathway involving miR‐29 and p53
Ugalde, A. P., Ramsay, A. J., de la Rosa, J., Varela, I., Mariño, G., Cadiñanos, J., Lu, J., Freije, J. M., & López‐Otín, C. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.124 · Cited by 254
Hyperplastic Cellular Remodeling of the Media in Ascending Thoracic Aortic Aneurysms
Tang, P. C. Y., Coady, M. A., Lovoulos, C. J., Dardik, A., Aslan, M., Elefteriades, J. A., & Tellides, G. (2005) · Circulation · doi:10.1161/circulationaha.104.511717 · Cited by 141
Bonauer, A., Boon, R. A., & Dimmeler, S. (2010) · Current Drug Targets · doi:10.2174/138945010791591313 · Cited by 131
Self-citationEtiology, pathogenesis and management of thoracic aortic aneurysm
İnce, H., & Nienaber, C. A. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0937 · Cited by 126
Ott, C., Grünhagen, J., Jäger, M., Horbelt, D., Schwill, S., Kallenbach, K., Guo, G., Manke, T., Knaus, P. I., Mundlos, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016250 · Cited by 122
The DIANA-mirExTra Web Server: From Gene Expression Data to MicroRNA Function
Alexiou, P., Maragkakis, M., Papadopoulos, G. L., Simossis, V. A., Zhang, L., & Hatzigeorgiou, A. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009171 · Cited by 91
Alterations in Aortic Cellular Constituents during Thoracic Aortic Aneurysm Development
Jones, J. A., Beck, C., Barbour, J. R., Zavadzkas, J. A., Mukherjee, R. D., Spinale, F. G., & Ikonomidis, J. S. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081141 · Cited by 66
Cited by
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
“…(Hill and Olson, 2008). miR-29 is downregulated under conditions of cardiovascular disease associated with fibrosis and excessive ECM production (Boon et al., 2011; Cushing et al., 2011; van Rooij et al., 2008), implicating this miRNA as a repressive mediator of fibrotic disease (Figure 3A).”
BackgroundAngiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
MicroRNA-34a regulates cardiac ageing and function.
Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., et al. (2013) · Nature · doi:10.1038/nature11919 · Cited by 821
Self-citationDevelopment of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625
Metadata
- Authors
- Boon, R. A., Seeger, T., Heydt, S., Fischer, A., Hergenreider, E., Horrevoets, A. J. G., Vinciguerra, M., Rosenthal, N., Sciacca, S., Pilato, M., van Heijningen, P., Essers, J., Brandes, R. P., Zeiher, A. M., & Dimmeler, S.
- Venue
- Circulation Research
- Published
- 2011-10-28
- Volume
- 109
- Issue
- 10
- Pages
- 1115-1119
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2158482287
- Cited by
- 366
- References
- 16
- FWCI
- 26.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.